12 Cutler Farm Road, Lexington, MA 02421 • 617/899-3364 • johnmcollinsphd@gmail.com
`
`John M. Collins, Ph.D.
`
`Summary
`A tested leader in technology-driven businesses with over 40 years of experience focused on
`accelerating the design, development, and commercialization of innovative technologies,
`products, and services. Experiences integrate a broad geographic and technology base across
`industries from clean energy/tech to consumer durables, with a career long focus on medical
`devices. A proven ability to form and lead high performance project and operational teams,
`create and manage strong intellectual property portfolios, as well as develop, structure, and
`drive collaborative business relationships with companies ranging from start-ups to premier
`multi-national organizations. Maintains a hands-on approach and an intimate working
`knowledge of technologies, operations, and user needs.
`Experience
`2008 to Present
`
`Boston, MA
`
`CIMIT: Consortia for Improving Medicine
`with Innovation and Technology
`
`Director, Innovation Platforms
`CIMIT is a consortium of the greater Boston area’s premier clinical, research and academic
`institutions with a growing network of national and international affiliates (www.CIMIT.org).
`Based at the Mass General Hospital, its mission is to improve patient care by facilitating
`collaboration among clinicians, engineers, and entrepreneurs to catalyze the discovery,
`development, and implementation of innovative technologies and procedures that improve
`patient care. John started as CIMIT’s Chief Operating Officer, being responsible for delivering
`CIMIT’s “Finding, Funding, Facilitation and Following” functions to supported teams. Over the
`years he led the development of web-enabled platforms that enabled the scaling of CIMIT’s
`support to collaborators in implementing CIMIT’s successful innovation model. He now focuses
`on supporting and growing the CIMIT network with the CRAASH, CoLab, and GAITS platforms.
`
`Lexington, MA
`
`Reed Collins LLC
`2008 to Present
`Chief Technology & Innovation Officer
`Technology, intellectual property, commercialization and business development consulting
`services for research teams, start-ups, IP law firms and risk capital organizations.
`2002 to 2008
`TIAX LLC
`Cambridge, MA
`President
`In close collaboration with CEO and owner, Dr. Kenan Sahin, formed TIAX from the Arthur D.
`Little T&I group. Established TIAX as a 150-person strong, privately held technology
`development and commercialization business, successfully blending services work for
`government and commercial clients with technology development and licensing. TIAX
`(www.TIAXLLC.com) is a unique technology “transformation” organization focused in several
`core technology areas, including clean energy and materials, health and wellness, appliances
`and HVAC systems, and enhanced security. The World Economic Forum recognized TIAX as a
`Technology Pioneer in 2002 and as a New Champion in 2007.
`Promoted to President in 2005 after having served as Executive Vice President since the
`company founding in 2002. In addition to an integral role in managing the transition and
`building a new business infrastructure, key accomplishments include attracting and hiring over
`60 exceptionally qualified staff members, developing key technology platforms and intellectual
`property portfolios, and establishing several significant collaborative business relationships and
`licensing agreements.
`
`
`Page 1 of 6
`
`
`
`October 2023
`
`JLI Ex. 2002, Page 1 of 8
`
`

`

`Cambridge, MA
`
`617/899-3364 • johnmcollinsphd@gmail.com
`John M. Collins, Ph.D.
`Arthur D Little, Inc
`1999 to 2002
`Senior Vice President, Technology & Innovation (T&I) Directorate
`Reporting to the President and serving on the company’s Executive Leadership Team,
`reestablished Arthur D. Little, Inc. (ADL) as a leader in technology consulting, linking strategy,
`innovation, and technology development. Architected and drove the turnaround of the
`technology business, reversing a declining revenue trend that persisted over several years to
`generate an average of ~20% annual growth. Successfully built a strong leadership team and
`focused the business on the integrated services of technology-based consulting, technology
`and product development, and intellectual property management. Grew the business to about
`300 staff members and operated above target profitability levels (20% contribution margin).
`Drove a number of large commercial relationships that created significant success for clients.
`Board member of Cambridge Consultants Ltd. (a wholly owned subsidiary based in
`Cambridge U.K.), Nuvera Fuel Cells (an ADL spin-out with interests held by Gruppo De Nora
`and Amerada Hess, based in Cambridge, MA) and Strategic Food Solutions (a joint venture
`between ADL and TNO, the Netherlands research organization).
`
`
`Sydney, Australia
`
`Arthur D Little, Inc
`1996 to 1999
`Managing Director, Asia Pacific Management Consulting Directorate
`Reporting to the President and serving on the company’s Executive Leadership Team,
`restructured Arthur D. Little’s Management Consulting business in Asia during the currency crisis
`of the late 90’s. Aligned the offices in Sydney, Melbourne, Singapore, Tokyo, Seoul, Kuala Lumpur
`and Hong Kong to achieve services revenues of about $30mm. Enabled the growth of ADL’s
`three lines of business (Technology, Environment and Management Consulting) by
`expanding/extending relationships with multi-national corporations based in the US and Europe.
`
`Initially, served as the Managing Director of the Sydney office and a member of the Asia Pacific
`Leadership team for two years before being promoted. In that time, opened an office in Melbourne
`and doubled the in-country revenues, returning the Australian operation to profitability, while also
`leading the expansion of the Technology & Innovation Management and the Organizational
`Learning practice across Asia Pacific.
`
`
`1988 to 1996
`
`Arthur D Little, Inc
`
`Cambridge, MA
`
`Booz, Allen & Hamilton
`
`Cleveland, Ohio
`
`Vice President, Technology and Product Development
`Joined Arthur D. Little, Inc. after completing Ph.D. to help establish the medical products group.
`Held a variety of positions of increasing responsibility while also maintaining an active hand in
`creating and managing engagements with clients. Created and implemented ADL’s Product
`Development Process.
`
`1982 to 1986
`Senior Consultant
`Held a variety of positions of increasing responsibility, transitioning from being a contributor in
`technology and strategy assignments to being a project leader.
`
`
`
`
`
`
`Page 2 of 6
`
`
`
`February, 2024
`
`JLI Ex. 2002, Page 2 of 8
`
`

`

`617/899-3364 • johnmcollinsphd@gmail.com
`John M. Collins, Ph.D.
`
`Doctorate in Mechanical Engineering from Massachusetts
`Institute of Technology, with a concentration in fluid mechanics
`and heat/mass transfer. Minor concentration in Technology &
`Innovation Management.
`Masters in Mechanical Engineering from Massachusetts Institute
`of Technology, with a concentration in fluids mechanics and
`heat/mass transfer. Minor concentration in Technology &
`Innovation Management.
`Bachelors in Mechanical Engineering from Rensselaer
`Polytechnic Institute, with a minor in Economics. General Motors
`Scholar/Intern.
`
`Over 20 US patents, with numerous corresponding international
`patents (see below)
`See below
`
`DoD Top Secret (no longer active)
`
`
`Education
`Ph.D. – MIT
`1987 to 1988
`
`
`M.S. – MIT
`1980 to 1982
`
`
`B.S. – RPI
`1976 to 1980
`
`Other
`Patents
`
`Recent Publications
`
`Security Clearance
`
`
`
`Page 3 of 6
`
`
`
`February, 2024
`
`JLI Ex. 2002, Page 3 of 8
`
`

`

`617/899-3364 • johnmcollinsphd@gmail.com
`John M. Collins, Ph.D.
`Issued US Patents
`
`
`
`Title
`
`Frozen food storage and dispensing system
`Frying apparatus
`Frozen food storage and dispensing system
`Frozen food storage & dispensing system
`Automated deep fat fryer
`
`
`Blood warming apparatus
`Container for use with blood warming apparatus
`
`
`Venturi spray nozzle for a cleaning device
`Liquid and detergent mixing chamber and valves
`
`
`Date Issued
`Patent Number
`Trocars for Minimally Invasive Surgery
`US5350364
`09/27/1994
`Universal seal for trocar assembly
`US5342315
`08/30/1994
`Trocar seal/protector assemblies
`US5314417
`05/24/1994
`Safety trocar
`US5209736
`05/11/1993
`Trocar method and apparatus
`US5197955
`03/30/1993
`Universal seal for trocar assembly
`
`
`
`Automated Fryer
`06/14/1994
`US5319939
`07/27/1993
`US5230279
`07/06/1993
`US5224415
`04/26/1994
`US5305615
`09/01/1992
`US5142968
`
`
`Blood/Fluid Warmer
`US6047108
`04/04/2000
`US5846224
`12/08/1998
`
`
`Rug Cleaner
`12/15/1987
`US4712740
`02/18/1986
`US4570856
`
`
`Catalytic Coating Process
`US4550034
`10/29/1985 Method of impregnating ceramic monolithic
`structures with predetermined amounts of
`catalyst
`09/02/1986 Metered charge system for catalytic coating of a
`substrate
`
`
`US4609563
`
`
`
`
`Ergonomic Table
`01/20/1987
`US4637322
`01/02/1990
`US4890561
`
`
`Tendon/ Ligament Repair
`US6106556
`08/22/2000
`US6080192
`06/27/2000
`US5800544
`09/01/1998
`
`
`
`Adjustable computer worktable
`Extendable keyboard support assembly
`
`
`Tendon and ligament repair system
`Tendon and ligament repair system
`Tendon and ligament repair system
`
`
`
`
`
`
`Page 4 of 6
`
`
`
`February, 2024
`
`JLI Ex. 2002, Page 4 of 8
`
`

`

`617/899-3364 • johnmcollinsphd@gmail.com
`John M. Collins, Ph.D.
`Recent Publications
`
`
`Accelerating the Healthcare Innovation Cycle
`IEEE Pulse, December 3, 2013
`A description of the CIMIT Model for stimulating and accelerating healthcare
`innovations into practice
`
`Facilitating Translational Research
`Journal of Investigative Dermatology, May 1, 2015
`An overview of the need for and CIMIT's approach to facilitating translational
`medical research.
`
`Deep Innovation in the Medical Domain a la Boston's CIMIT
`Venture Findings #3, November 25, 2015
`An overview of how the CIMIT Model supports innovation
`
`National Institute of Biomedical Imaging and Bioengineering Point-of-Care
`Technology Research Network: Advancing Precision Medicine
`IEEE Journal of Transnational Engineering in Health and Medicine, August 16,
`2016
`This paper describes the Point-of-Care Technology Research Network and the
`three Centers funded by NIBIB as examples of academic-based organizations
`that support collaborations across disciplines, institutions, and geographic
`regions to successfully drive innovative solutions from concept to patient care.
`
`Healthcare Commercialization Programs: Improving the Efficiency of
`Translating Healthcare Innovations from Academia Into Practice
`IEEE Journal of Transnational Engineering in Health and Medicine, September
`28, 2016
`The article describes Healthcare Commercialization Programs (HCPs) which
`offer institutions and funders an additional option to improve the efficiency with
`which the healthcare projects translate into products and services that improve
`people’s health. It describes programs such as CIMIT's CRAASH course that get
`teams out of the lab to interface with customers and stakeholders.
`
`Healthcare innovation methodology: codifying the process of translating
`knowledge into better healthcare products, services, and procedures
`Current Opinion in Biomedical Engineering 2019, 11:16–21
`This article provides an overview of the differences between research and
`innovation and discusses why treating them as distinct processes is important
`to help maximize the successful translation of research into population health
`benefits.
`
`The Role of CoLab and GAITS in Enabling the RADx Tech Program
`IEEE Open Journal of Engineering in Medicine and Biology, VOL. 2, 2021, pages
`199 to124
`
`Page 5 of 6
`
`
`
`February, 2024
`
`JLI Ex. 2002, Page 5 of 8
`
`

`

`617/899-3364 • johnmcollinsphd@gmail.com
`John M. Collins, Ph.D.
`This article describes how two of CIMIT’s Innovation platforms, GAITS and
`CoLab enabled the RADx program to rapidly mobilize the biomedical community
`in developing tests to detect the SARS-CoV-2 virus.
`
`RADx Tech Viability and Steering Panels: A Model for MedTech
`Translational Grant Review
`IEEE Open Journal of Engineering in Medicine and Biology, VOL. 2, 2021, pages
`125 to130
`This article describes how the highly experienced members of the RADx Tech
`Viability and Steering Panels worked in a process to “assess, improve, and then
`select” which resulted in improved timing, efficiency, and effectiveness of
`reviews.
`
`The RADx Tech Deep Dive and Work Package 1 Process
`IEEE Open Journal of Engineering in Medicine and Biology, VOL. 2, 2021, pages
`131 to137
`This article describes the novel Deep Dive and Work Package 1 phases of RADx
`Tech which enabled comprehensive project reviews and project de-risking at
`unprecedent speeds.
`
`Page 6 of 6
`
`
`
`February, 2024
`
`JLI Ex. 2002, Page 6 of 8
`
`

`

`
`
`
`
`
`Prior Cases in which Dr. Collins Served as an Expert Witness
`As of February 2024
`
`Case
`IPR2014-01289 and
`IPR2014-01300
`
`Subject
`Electronic Cigarette
`
`Parties
`NJOY, INC., Petitioner,
`vs.Fontem Holdings 1 B.V.,
`Patent Owner.
`Fontem Holdings B.V., vs.
`NJOY, INC., et al.
`
`Nu Mark LLC vs. Fontem
`Holdings 1, B.V.
`
`Electronic Cigarette
`
`Electronic Cigarette
`
`Consolidated Case
`No. CV 14-01645 GW
`(MRW)
`IPR2016-01773,
`IPR2016-01641,
`IPR2016-01664,
`IPR2016-01707,
`IPR2016-01706,
`IPR2016-01705,
`IPR2016-01668, and
`IPR2016-01642
`US ITC Investigation
`No. 337-TA-1139 and
`No. 337-TA-1141
`Below are Cases in the Last 4 Years
`Trudell Medical Int’l, Plaintiff,
`Civil Action No.: 4:18-
`Oscillating Positive
`vs. D R Burton Healthcare
`cv-00008-H-KS
`Pressure Respiratory
`LLC,
`Devices
`C.R. Bard, Inc., et.al vs.
`Vascular access ports
`Medical Components, Inc.
`Fuma International, LLC vs.
`RJ Reynolds Vapor
`Company
`Purewick Corp. vs. Sage
`Products LLC
`Fisher & Paykel Healthcare
`Limited vs. Flexicare Inc., et
`al.
`
`
`Altria Client Services LLC, et
`al. vs. R.J Reynolds Vapor
`Company, et al.
`The Travelers Property
`Casualty Company of America
`vs. LG Chem Power, Inc., et
`al.
`Inexian Corporation vs.
`Venable LLP
`Beijing Choice vs. Contec
`Medical Systems
`Facet Technologies LLC, vs.
`Lifescan, Inc.
`Lifescan, Inc. vs. Facet
`Technologies LLC.
`
`Juul Labs, Inc vs. Eon Smoke
`et. al.
`
`Electronic Nicotine
`Delivery Systems
`
`Case No.: 2:17-cv-
`00754-HCN-DAO
`Case Nos 1:19-cv-
`00260 and 1:19-cv-
`00660
`C.A No. 19-1508-MN Urine Collection Device
`
`Electronic Cigarettes
`
`Case No. 8:19-CV-
`00835JVS (DFMx)
`
`Ventilatory Breathing
`Tubes
`
`Case No.: 1:20-cv-
`00472-NCT-JLW
`
`Case No. 6:18-CV-
`01728-JD
`
`Case No. 24-C-21-
`000200
`Civil Action No. 1:18-
`cv-00825 (NDIL)
`Case No. 2:22-cv-
`01717-MCS-MAR
`IPR2023-00712, and
`IPR2023-00713
`
`Electronic Cigarettes
`
`Condensation in
`Lithium-Ion Battery
`Packs
`
`Electronic Cigarettes
`
`Fingertip Pulse
`Oximeters
`Medical Lancets
`
`Medical Lancets
`
`
`February 2024
`Note: I submitted expert reports and/or testified on behalf of the parties in bold.
`
`Page 1 of 2
`
`JLI Ex. 2002, Page 7 of 8
`
`

`

`
`
`Purewick Corp. vs. Sage
`Products LLC
`C.R. Bard, Inc. and Bard
`Peripheral Vascular, Inc. vs.
`Angiodynamics, Inc.
`Provisur Technologies Inc.
`vs. Weber Maschinenbau
`GMBH Breidenbach
`NJOY Netherlands BV vs.
`VMR Products LLC.
`
`
`
`C.A. No. 22-102-MN-
`JLH
`C.A. No. 20-1544
`(CFC)
`
`Urine Collection Device
`
`Vascular access ports
`
`IPR2024-00235.
`IPR2024-00224
`
`Food handling
`equipment
`
`Electronic Cigarettes
`
`UPC Case Numbers:
`ACT_571537/2023
`(EP2875740),
`ACT_571565/2023
`(EP3456214),
`ACT_571730/2023
`(EP3613453), and
`ACT_571745/2023
`(EP3626092)
`
`
`February 2024
`Note: I submitted expert reports and/or testified on behalf of the parties in bold.
`
`Page 2 of 2
`
`JLI Ex. 2002, Page 8 of 8
`
`